Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.

We have identified the presence of leupaxin (LPXN), which belongs to the paxillin extended family of focal adhesion-associated adaptor proteins, in prostate cancer cells. Previous studies have demonstrated that LPXN is a component of the podosomal signaling complex found in osteoclasts, where LPXN was found to associate with the protein tyrosine kinases Pyk2 and c-Src and the cytosolic protein tyrosine phosphatase-proline-, glutamate-, serine-, and threonine-rich sequence (PTP-PEST). In the current study, LPXN was detectable as a 50-kDa protein in PC-3 cells, a bone-derived metastatic prostate cancer cell line. In PC-3 cells, LPXN was also found to associate with Pyk2, c-Src, and PTP-PEST. A siRNA-mediated inhibition of LPXN resulted in decreased in vitro PC-3 cell migration. A recombinant adenoviral-mediated overexpression of LPXN resulted in an increased association of Pyk2 with LPXN, whereas a similar adenoviral-mediated overexpression of PTP-PEST resulted in decreased association of Pyk2 and c-Src with LPXN. The overexpression of LPXN in PC-3 cells resulted in increased migration, as assessed by in vitro Transwell migration assays. On the contrary, the overexpression of PTP-PEST in PC-3 cells resulted in decreased migration. The overexpression of LPXN resulted in increased activity of Rho GTPase, which was decreased in PTP-PEST-overexpressing cells. The increase in Rho GTPase activity following overexpression of LPXN was inhibited in the presence of Y27632, a selective inhibitor of Rho GTPase. In conclusion, our data demonstrate that LPXN forms a signaling complex with Pyk2, c-Src, and PTP-PEST to regulate migration of prostate cancer cells.

[1]  T. Barrette,et al.  Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.

[2]  D. Staunton,et al.  Leupaxin Is a Novel LIM Domain Protein That Forms a Complex with PYK2* , 1998, The Journal of Biological Chemistry.

[3]  A. Veillette,et al.  PTP‐PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates , 2001, The EMBO journal.

[4]  D. Fabbro,et al.  Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro. , 2003, European journal of cancer.

[5]  C. Turner,et al.  Paxillin is essential for PTP-PEST-dependent regulation of cell spreading and motility: a role for paxillin kinase linker , 2005, Journal of Cell Science.

[6]  B. Druker,et al.  RAFTK, a Novel Member of the Focal Adhesion Kinase Family, Is Phosphorylated and Associates with Signaling Molecules upon Activation of Mature T Lymphocytes , 1997, The Journal of experimental medicine.

[7]  S. Sahu,et al.  Association of leupaxin with Src in osteoclasts. , 2007, American journal of physiology. Cell physiology.

[8]  S. Andò,et al.  Loss of proline‐rich tyrosine kinase 2 function induces spreading and motility of epithelial prostate cells , 2006, Journal of cellular physiology.

[9]  Keith Burridge,et al.  Front and back by Rho and Rac , 2006, Nature Cell Biology.

[10]  M. Schaller,et al.  The Noncatalytic Domain of Protein-tyrosine Phosphatase-PEST Targets Paxillin for Dephosphorylation in Vivo * , 2000, The Journal of Biological Chemistry.

[11]  P. Chieffi,et al.  Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells , 2002, Molecular and Cellular Endocrinology.

[12]  J. Hsieh,et al.  Characterization of a Novel Negative Regulator (DOC-2/DAB2) of c-Src in Normal Prostatic Epithelium and Cancer* , 2003, The Journal of Biological Chemistry.

[13]  R. Thapar,et al.  Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors. , 2005, Biochemistry.

[14]  K. Mashima,et al.  Leupaxin binds to PEST domain tyrosine phosphatase PEP , 2005, Molecular and Cellular Biochemistry.

[15]  E. Rosen,et al.  Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection , 2005, Oncogene.

[16]  C. Heldin,et al.  Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. , 2002, Molecular biology of the cell.

[17]  M. Tremblay,et al.  Protein Tyrosine Phosphatase-PEST Regulates Focal Adhesion Disassembly, Migration, and Cytokinesis in Fibroblasts , 1999, The Journal of cell biology.

[18]  C. Logothetis,et al.  Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins. , 2000, Cell calcium.

[19]  M. Roberts,et al.  Paxillin Associates with Poly(A)-binding Protein 1 at the Dense Endoplasmic Reticulum and the Leading Edge of Migrating Cells* , 2002, The Journal of Biological Chemistry.

[20]  J. Couchman,et al.  RhoGDI: multiple functions in the regulation of Rho family GTPase activities. , 2005, The Biochemical journal.

[21]  G. Rodan,et al.  Integrins and signaling in osteoclast function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[22]  G. Rodan,et al.  PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. , 1998, The Journal of clinical investigation.

[23]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[24]  C. Turner,et al.  JCB Article , 2001 .

[25]  M. Ishino,et al.  Nuclear translocation of cell adhesion kinase beta/proline-rich tyrosine kinase 2. , 2002, Cell structure and function.

[26]  J. Cheng,et al.  Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. , 2005, Cancer research.

[27]  C. Myers,et al.  Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. , 2000, Biochemical and biophysical research communications.

[28]  E. Schaefer,et al.  Inhibition of the Catalytic Activity of Cell Adhesion Kinase β by Protein-tyrosine Phosphatase-PEST-mediated Dephosphorylation* , 2001, The Journal of Biological Chemistry.

[29]  Haibin Xia,et al.  A simple method for the rapid generation of recombinant adenovirus vectors , 2000, Gene Therapy.

[30]  D. Schlaepfer,et al.  Focal adhesion kinase functions as a receptor-proximal signaling component required for directed cell migration , 2000, Immunologic research.

[31]  Beth S. Lee,et al.  Leupaxin Is a Critical Adaptor Protein in the Adhesion Zone of the Osteoclast , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Shin-Young Park,et al.  RAFTK/Pyk2-mediated cellular signalling. , 2000, Cellular signalling.

[33]  E. Yang,et al.  Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells , 2004, Oncogene.

[34]  Y. Daaka.  Mitogenic action of LPA in prostate. , 2002, Biochimica et biophysica acta.

[35]  K. Pienta,et al.  The Role of αvβ3 in Prostate Cancer Progression , 2002 .

[36]  M. Sheetz,et al.  Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Lev,et al.  A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.

[38]  A. Woodard,et al.  Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. , 1999, Cancer research.

[39]  Kenneth M. Yamada,et al.  Cell–matrix adhesion , 2007, Journal of cellular physiology.

[40]  A. Bilancio,et al.  Sex steroid hormones act as growth factors , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  P. Stricker,et al.  Growth factor involvement in progression of prostate cancer. , 1998, Clinical chemistry.

[42]  Xu Feng,et al.  PYK2 and FAK in osteoclasts. , 2003, Frontiers in bioscience : a journal and virtual library.

[43]  S. Kukreja,et al.  Development of skeletal metastasis by human prostate cancer in athymic nude mice , 1988, Clinical & Experimental Metastasis.

[44]  A. Atfi,et al.  Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways. , 1994, The Journal of biological chemistry.

[45]  G. Mize,et al.  Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. , 2003, Biochemistry.

[46]  S. Yeh,et al.  Suppression of Androgen Receptor Transactivation by Pyk2 via Interaction and Phosphorylation of the ARA55 Coregulator* , 2002, The Journal of Biological Chemistry.

[47]  D. DeFranco,et al.  Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells. , 2006, Cancer research.

[48]  J. Parsons,et al.  Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells , 2001, Oncogene.

[49]  A. Woodard,et al.  Substrate Specificity of αvβ3Integrin-mediated Cell Migration and Phosphatidylinositol 3-Kinase/AKT Pathway Activation* , 2000, The Journal of Biological Chemistry.

[50]  G. Rocklin,et al.  Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. , 2006, Molecular biology of the cell.

[51]  C. Turner.  Molecules in focus Paxillin , 1998 .

[52]  Alexander Marks,et al.  Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor. , 2002, Endocrinology.

[53]  H. Kung,et al.  Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK , 2004, Oncogene.

[54]  M. Stearns.  Alendronate blocks TGF-β1 stimulated collagen 1 degradation by human prostate PC-3 ML cells , 1998, Clinical & Experimental Metastasis.

[55]  A. Bilancio,et al.  Rapid signalling pathway activation by androgens in epithelial and stromal cells , 2004, Steroids.

[56]  J. Henley,et al.  CAKβ/Pyk2 Activates Src Another Piece in the Puzzle of LTP Induction , 2001, Neuron.

[57]  S. Sahu,et al.  Expression of the zinc transporter ZIP1 in osteoclasts. , 2005, Bone.

[58]  J. Bohl,et al.  Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase , 2002, Oncogene.

[59]  C. Turner,et al.  Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region. , 1994, Journal of cell science.

[60]  Michael D Schaller,et al.  The interplay between Src and integrins in normal and tumor biology , 2004, Oncogene.

[61]  K. Pienta,et al.  The role of alpha(v)beta(3) in prostate cancer progression. , 2002, Neoplasia.

[62]  K. Nose,et al.  Accumulation of Focal Adhesion Protein Hic-5 in the Nucleus by Hydrogen Peroxide , 2001 .

[63]  D. DeFranco,et al.  The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. , 2003, Cancer research.

[64]  C. Turner,et al.  Paxillin interactions. , 2000, Journal of cell science.

[65]  R. Franco,et al.  Variations of Proline-Rich Kinase Pyk2 Expression Correlate with Prostate Cancer Progression , 2001, Laboratory Investigation.

[66]  M. Schaller,et al.  PTP-PEST controls motility through regulation of Rac1 , 2002, Journal of Cell Science.

[67]  J. Hodge,et al.  Lysophosphatidic acid stimulates PC‐3 prostate cancer cell matrigel invasion through activation of RhoA and NF‐κB activity , 2006, Molecular carcinogenesis.

[68]  C. Turner,et al.  Paxillin: adapting to change. , 2004, Physiological reviews.

[69]  C. Der,et al.  Vav2 Is an Activator of Cdc42, Rac1, and RhoA* , 2000, The Journal of Biological Chemistry.

[70]  M. Ishino,et al.  Nuclear Translocation of Cell Adhesion Kinase β/Proline-rich Tyrosine Kinase 2 , 2002 .

[71]  K. Burridge,et al.  Regulation of Cell Adhesion by Protein-tyrosine Phosphatases , 2006, Journal of Biological Chemistry.

[72]  S. Chevalier,et al.  Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo. , 1996, Molecular endocrinology.

[73]  G. E. Jones,et al.  Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering. , 2005, Cell motility and the cytoskeleton.

[74]  J. Cloutier,et al.  Direct Association of Protein-tyrosine Phosphatase PTP-PEST with Paxillin* , 1998, The Journal of Biological Chemistry.

[75]  M. Tremblay,et al.  PTP-PEST Couples Membrane Protrusion and Tail Retraction via VAV2 and p190RhoGAP* , 2006, Journal of Biological Chemistry.

[76]  R. Franklin,et al.  Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. , 2006, Bone.

[77]  J. Camonis,et al.  RhoGAPs and RhoGDIs, (His)stories of two families. , 1999, Progress in molecular and subcellular biology.

[78]  C. V. Golen,et al.  RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility , 2006, Oncogene.

[79]  Shin-Young Park,et al.  RAFTK/Pyk2 mediates LPA-induced PC12 cell migration. , 2006, Cellular signalling.

[80]  K. Nose,et al.  Transcriptional activation of the c-fos gene by a LIM protein, Hic-5. , 2002, Biochemical and biophysical research communications.

[81]  Michael D Schaller,et al.  Paxillin: a focal adhesion-associated adaptor protein , 2001, Oncogene.

[82]  A. Alcover,et al.  Vav proteins, masters of the world of cytoskeleton organization. , 2004, Cellular signalling.